Bevacizumab Approved for Late-Stage Cervical Cancer (FREE)

By Kristin J. Kelley Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH The FDA has approved bevacizumab (Avastin) for metastatic, persistent, or recurrent cervical cancer to be used in combination with …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news